Adrie Gunther
About
In The Last Decade
Adrie Gunther
4 papers receiving 392 citations
Peers
Comparison fields: 5 of 61
- Molecular Biology 174
- Urology 172
- Rheumatology 140
- Epidemiology 136
- Oncology 98
Countries citing papers authored by Adrie Gunther
This map shows the geographic impact of Adrie Gunther's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adrie Gunther with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adrie Gunther more than expected).
Fields of papers citing papers by Adrie Gunther
This network shows the impact of papers produced by Adrie Gunther. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adrie Gunther. The network helps show where Adrie Gunther may publish in the future.
Co-authorship network of co-authors of Adrie Gunther
This figure shows the co-authorship network connecting the top 25 collaborators of Adrie Gunther. A scholar is included among the top collaborators of Adrie Gunther based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adrie Gunther. Adrie Gunther is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 184 | |
| 2 | 210 | |
| 3 | 1 | |
| 4 | A phase II, monotherapy study of YM155, a novel survivin suppressant, in previously treated advanced stage non-small cell lung cancer (NSCLC) | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.